Table 3 Distribution of level of AF-alb concentration (pg/mg albumin) with respect to stunted and non-stunted cases.
Study | *Total study population | Children with stunting (HAZ < − 2) | Children at co-occurrence (HAZ and WAZ < − 2) | Children with no stunting (HAZ > − 2) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
No | % | AF-alb conc. pg/mg (95%CI) | No | % | AF-alb conc. pg/mg (95%CI) | No | % | AF-alb conc. pg/mg (95%CI) | ||
Tanzania | 146 | 82 | 56.2 | 52.06 (23.31–80.81) | 19 | 13.0 | 31.57 (13.24–49.91) | 63 | 43.2 | 40.01 (27.15–52.867) |
Gambia | 350 | 76 | 21.7 | 88.11 (67.03–109.18) | 45 | 12.9 | 76.88 (57.19–96.56) | 272 | 77.7 | 91.95 (74.48–109.41) |
Benin & Togo | 456 | 149 | 33.0 | 88.00 (65.28–110.73) | 92 | 20.2 | 106.69 (72.49–140.90) | 306 | 67.0 | 48.08 (41.09–55.15) |
Benin | 193 | 76 | 39.4 | 229.95 (175.02–284.87) | 53 | 28.0 | 250.48 (182.94–318.01) | 115 | 59.6 | 130.15 (94.634–165.66) |
Overall | 1145 | 383 | 33.5 | 109.41 (92.04–126.77) | 209 | 18.3 | 132.37 (106.31–158.43) | 756 | 66.0 | 75.01 (66.04–83.97) |
